Question 1

How many institutions own KAPA stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own KAPA shares is 13, representing 5.37% of the company's common stock.

Question 2

Who are the major shareholders selling Kairos Pharma, Ltd. stock?

Accepted Answer

N/A, in the last quarter, reduced its stake in KAPA by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the KAPA shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned KAPA shares holding by N/A last quarter which brought its holding to - shares worth -.

Question 3

Investors who are buying KAPA stock?

Accepted Answer

As per its latest 13F filing, N/A increased its stake in KAPA by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of KAPA to its portfolio, raising its holding to - shares of worth -. N/A also increased its KAPA shares holding by N/A which brought its holding to - shares worth -.

Question 4

KAPA's major insiders: who are they?

Accepted Answer

The insider with the most stakes in KAPA is Yu John S , CEO and Chairman at the company. Additionally, KAPA stock is highly held by VP of Research and Development Murali Ramachandran and Chief Financial Officer Samuelson Doug among others.

Question 5

Did an insider recently sell KAPA stock?

Accepted Answer

Company executives, directors, and other insiders own 38.38% percent of Kairos Pharma, Ltd.'s stock. Within the last six months, there have been 0 transaction(s) in which KAPA insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Question 6

Which insider recently purchased KAPA stock?

Accepted Answer

There have been 0 transaction(s) during the past 6-months in which Kairos Pharma, Ltd. insiders have bought stock, totalling 0 shares

Question 7

How much of KAPA does insiders own?

Accepted Answer

Around 0 Kairos Pharma, Ltd. shares are held by insiders, which represents about 38.38% of KAPA stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

KAPA CEO and Chairman, Yu John S holds the largest portfolio of the company's shares. KAPA shares owned by Yu total nearly 5.34 million.

Question 9

Which institution holds the most shares in KAPA?

Accepted Answer

N/A is the largest institutional owner in KAPA which holds - shares worth - or N/A of the total KAPA shares outstanding followed by N/A with ownership of - shares representing N/A of the KAPA ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Question 10

Is Kairos Pharma, Ltd. stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the KAPA is concerned, it is a stock which is not optionable.

Question 11

Is there a short position on KAPA's shares?

Accepted Answer

Number of KAPA shares short is 869.28K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding KAPA shares are there?

Accepted Answer

As of today, 20.74M shares of KAPA are outstanding.

Question 13

Is there many float in KAPA stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, KAPA has 11.81M shares in float.

Question 14

KAPA short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for KAPA is 0.07.

Insiders	Designation	Shares Held
YU JOHN S	CEO and Chairman	5.34M
MURALI RAMACHANDRAN	VP of Research and Development	133.06K
SAMUELSON DOUG	Chief Financial Officer	60.8K

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Nov 25, 2024	MURALI RAMACHANDRAN	PURCHASE	1.59	200	318	133.06K
Nov 22, 2024	SAMUELSON DOUG	PURCHASE	1.50	2.5K	3.75K	60.8K
Nov 20, 2024	YU JOHN S	PURCHASE	1.44	4K	5.76K	5.34M

Insiders	Designation	Shares Held
YU JOHN S	CEO and Chairman	5.34M
MURALI RAMACHANDRAN	VP of Research and Development	133.06K
SAMUELSON DOUG	Chief Financial Officer	60.8K

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Nov 25, 2024	MURALI RAMACHANDRAN	PURCHASE	1.59	200	318	133.06K
Nov 22, 2024	SAMUELSON DOUG	PURCHASE	1.50	2.5K	3.75K	60.8K
Nov 20, 2024	YU JOHN S	PURCHASE	1.44	4K	5.76K	5.34M

KAPA Stock Ownership Breakdown

Kairos Pharma

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Frequently Asked Questions